MORIERI, MARIO LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.486
AS - Asia 357
EU - Europa 316
AF - Africa 7
SA - Sud America 7
OC - Oceania 4
Totale 3.177
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.480
SG - Singapore 190
IT - Italia 184
CN - Cina 140
FR - Francia 40
FI - Finlandia 24
GB - Regno Unito 22
SE - Svezia 16
DE - Germania 13
VN - Vietnam 12
IN - India 9
CA - Canada 5
EG - Egitto 5
IE - Irlanda 5
UA - Ucraina 5
AU - Australia 4
PE - Perù 4
BR - Brasile 3
GA - Gabon 2
NL - Olanda 2
SI - Slovenia 2
ES - Italia 1
ID - Indonesia 1
IR - Iran 1
JO - Giordania 1
JP - Giappone 1
MX - Messico 1
PH - Filippine 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 3.177
Salva come PNG Salva come JPEG
Città #
Fairfield 459
Chandler 238
Woodbridge 188
Ashburn 176
Houston 174
Cambridge 169
Singapore 161
Seattle 158
Wilmington 126
Santa Clara 118
Boardman 72
San Diego 56
Ann Arbor 55
Medford 47
Princeton 47
Beijing 43
Des Moines 31
Roxbury 26
Padova 23
Helsinki 19
Dong Ket 11
New York 10
Rome 10
Cagliari 9
Guangzhou 9
London 9
Nanjing 9
Pescara 9
Dallas 6
Florence 6
Los Angeles 6
Milan 6
Pianella 6
Shanghai 6
Alexandria 5
Breganze 5
Lappeenranta 5
Pune 5
Redmond 5
Redwood City 5
Borås 4
Changsha 4
Jinan 4
Nanchang 4
Norwalk 4
Paris 4
Vicenza 4
Brendola 3
Dublin 3
Ogden 3
Piura 3
Pravisdomini 3
Rieti 3
San Francisco 3
Vicopisano 3
Zhengzhou 3
Acton 2
Agordo 2
Albignasego 2
Barrafranca 2
Council Bluffs 2
Crevalcore 2
Delhi 2
Desio 2
Duncan 2
Ferrara 2
Haikou 2
Hounslow 2
Jiujiang 2
Kharkiv 2
Libreville 2
Ljubljana 2
Maceió 2
Macerata 2
Massapequa 2
Mississauga 2
Modica 2
Naples 2
Ningbo 2
Nocera Inferiore 2
Ottawa 2
Paese 2
Pollenza 2
Rovigo 2
Taranto 2
Wandsworth 2
Washington 2
Amman 1
Amsterdam 1
Ancona 1
Ardabil 1
Arezzo 1
Bari 1
Bellante 1
Boca Raton 1
Brasília 1
Bratislava 1
Buccinasco 1
Charlotte 1
Civitanova Marche 1
Totale 2.658
Salva come PNG Salva come JPEG
Nome #
Improved long-term cardiovascular outcomes after intensive versus standard screening of diabetic complications: an observational study 121
Hyperglycemia, glucocorticoid therapy, and outcome of COVID-19 109
Farmacogenetica del fenofibrato: verso una medicina di precisione nella prevenzione delle complicanze micro e macro-vascolari del diabete 103
Adipokines levels in HIV infected patients: Lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation 103
Computerized cognitive training and brain derived neurotrophic factor during bed rest: Mechanisms to protect individual during acute stress 98
Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case-control study 95
Insufficient Evidence for Interaction Between Haptoglobin Phenotypes and Intensive Glycemic Control on Cardiovascular Outcomes 94
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration 89
Interleukin-6 "Trans-Signaling" and Ischemic Vascular Disease: The Important Role of Soluble gp130 88
Genetic tools for coronary risk assessment in type 2 diabetes: A cohort study from the ACCORD clinical trial 87
Brain-derived neurotrophic factor plasma levels: Relationship with dementia and diabetes in the elderly population 85
Exposure to dipeptidyl-peptidase 4 inhibitors and the risk of pneumonia among people with type 2 diabetes: Retrospective cohort study and meta-analysis 80
Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes 79
Genetic predictors of cardiovascular mortality during intensive glycemic control in type 2 diabetes: Findings from the ACCORD clinical trial 78
Fixed versus flexible combination of GLP-1 receptor agonists with basal insulin in type 2 diabetes: A retrospective multicentre comparative effectiveness study 75
Performance of the Steno type 1 risk engine for cardiovascular disease prediction in Italian patients with type 1 diabetes 74
Cholesterol lowering therapies and achievement of targets for primary and secondary cardiovascular prevention in type 2 diabetes: unmet needs in a large population of outpatients at specialist clinics 72
PPARA polymorphism influences the cardiovascular benefit of fenofibrate in type 2 diabetes: Findings from accord-lipid 65
Trend 2010–2018 in the clinical use of GLP-1 receptor agonists for the treatment of type 2 diabetes in routine clinical practice: an observational study from Northeast Italy 64
Uric acid within the “normal” range predict 9-year cardiovascular mortality in older individuals. The InCHIANTI study 64
Disease progression in HIV Late Presenters: The role of HIV clinical indicator diseases prior to HIV diagnosis 63
Modulation of GLP-1 levels by a genetic variant that regulates the cardiovascular effects of intensive glycemic control in ACCORD 62
Long-acting injectable glp-1 receptor agonists for the treatment of adults with type 2 diabetes: Perspectives from clinical practice 61
Prevalence and impact of diabetes among people infected with SARS-CoV-2 58
Paraoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage 57
Combining LDL-C and HDL-C to predict survival in late life: The InChianti study 57
Comparative effectiveness of dapagliflozin vs DPP-4 inhibitors on a composite endpoint of HbA1c, body weight, and blood pressure reduction in the real world 55
Association of Hypomorphic P2X7 Receptor Genotype With Age 53
Prevalence of hepatic steatosis in patients with type 2 diabetes and response to glucose-lowering treatments. A multicenter retrospective study in Italian specialist care 53
Fenofibrate increases circulating haematopoietic stem cells in people with diabetic retinopathy: a randomised, placebo-controlled trial 53
Effectiveness of dulaglutide in the real world and in special populations of type 2 diabetic patients 51
Variants in ANGPTL4 and the Risk of Coronary Artery Disease 49
Low-grade systemic inflammation is associated with functional disability in elderly people affected by dementia 48
Lower Plasma Klotho Concentrations Are Associated with Vascular Dementia but Not Late-Onset Alzheimer's Disease 47
First case of 2 intraductal papillary mucinous tumors of both ventral and dorsal ducts in pancreas divisum 46
Determinants and clinical significance of plasma oxidized LDLs in older individuals. A 9 years follow-up study 44
PPARγ Pro12Ala and ACE ID polymorphisms are associated with BMI and fat distribution, but not metabolic syndrome 41
Effectiveness of dulaglutide vs liraglutide and exenatide once-weekly. A real-world study and meta-analysis of observational studies 40
Long-term cardiovascular outcome after intensive versus standard screening of diabetic complications: a real-word observational study 39
The Toll of Lockdown Against COVID-19 on Diabetes Outpatient Care: Analysis From an Outbreak Area in Northeast Italy 38
Gene expression regional differences in human subcutaneous adipose tissue 35
In hospital risk factors for acute kidney injury and its burden in patients with Sars-Cov-2 infection: a longitudinal multinational study 33
Age-related differences in plasma BDNF levels after prolonged bed rest 30
Explainable Deep-Learning Model Reveals Past Cardiovascular Disease in Patients with Diabetes Using Free-Form Visit Reports 28
Performance assessment across different care settings of a heart failure hospitalisation risk-score for type 2 diabetes using administrative claims 28
The Fast-Glycator Phenotype, Skin Advanced Glycation End Products, and Complication Burden Among People With Type 1 Diabetes 25
Why diabetes outpatient clinics should not close during pandemic crises 25
Changes in markers of hepatic steatosis and fibrosis in patients with type 2 diabetes during treatment with glucagon-like peptide-1 receptor agonists. A multicenter retrospective longitudinal study 25
Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist Care 24
null 24
Insulin resistance and systemic inflammation, but not metabolic syndrome phenotype, predict 9 years mortality in older adults 23
Deciphering dementia in the cardiometabolic continuum 20
Time-series analysis of multidimensional clinical-laboratory data by dynamic Bayesian networks reveals trajectories of COVID-19 outcomes 19
Deep-learning-based natural-language-processing models to identify cardiovascular disease hospitalisations of patients with diabetes from routine visits' text 17
Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets’ attainment in subjects with and without type 2 diabetes 16
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus 15
Prevalence and risk factors of glomerular hyperfiltration in adults with type 2 diabetes: A population-based study 14
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus 14
Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study 13
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk 13
Deviations from the ADA/EASD treatment algorithm is associated with higher cardiovascular events and death in type 2 diabetes under routine care 13
Sex differences in cardiovascular disease and cardiovascular risk estimation in patients with type 1 diabetes 12
Management of type 2 diabetes with a treat-to-benefit approach improved long-term cardiovascular outcomes under routine care 11
Improved prediction of long-term kidney outcomes in people with type 2 diabetes by levels of circulating haematopoietic stem/progenitor cells 10
Serum Orotidine: A Novel Biomarker of Increased CVD Risk in Type 2 Diabetes Discovered Through Metabolomics Studies 9
Glucose-lowering drugs with cardiovascular benefits as modifiers of critical elements of the human life history 8
Heart Failure Burden in Diabetes: Can Fenofibrate Provide Additional Hope? 8
Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus 7
Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care 3
Totale 3.260
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.588
article - articoli 15.736
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.324
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020258 0 0 0 0 33 17 37 41 45 42 28 15
2020/2021868 21 10 58 37 340 41 60 63 84 32 83 39
2021/2022612 39 49 53 18 50 73 18 52 78 16 36 130
2022/2023472 91 64 17 43 62 46 10 37 56 8 30 8
2023/2024399 17 48 21 28 21 47 62 17 15 24 48 51
2024/2025517 25 197 68 62 165 0 0 0 0 0 0 0
Totale 3.260